Keryx to present data on perifosine at ASH meeting
Publicado: Jue Dic 03, 2009 10:57 pm
Keryx to present data on perifosine at ASH meeting
Fuente:
SmartBrief IMF
http://money.cnn.com/news/newsfeeds/art ... _MO556.htm
"Keryx Biopharmaceuticals will present data from a Phase 1/2 clinical trial of perifosine in combination with bortezomib in patients with relapsed/refractory multiple myeloma at the ASH annual meeting, being held Dec. 5 to 8"
Saludos
Traducción:
http://www.translate.google.es/translat ... l=en&tl=es
Fuente:
SmartBrief IMF
http://money.cnn.com/news/newsfeeds/art ... _MO556.htm
"Keryx Biopharmaceuticals will present data from a Phase 1/2 clinical trial of perifosine in combination with bortezomib in patients with relapsed/refractory multiple myeloma at the ASH annual meeting, being held Dec. 5 to 8"
Saludos
Traducción:
http://www.translate.google.es/translat ... l=en&tl=es